Role of megalin and the soluble form of its ligand RAP in Cd-metallothionein endocytosis and Cd-metallothionein-induced nephrotoxicity in vivo

详细信息    查看全文

• 作者：Akira Onodera ; Miyuki Tani ; Toshimi Michigami ; Masayo Yamagata ; Kyong-Son Min ; Keiichi Tanaka ; Tsuyoshi Nakanishi ; Tomoki Kimura ; Norio Itoh
• 关键词：Metallothionein ; Cadmium ; sRAP ; Megalin ; Lrp2 ; Lrpap1
• 刊名：Toxicology Letters
• 出版年：2012
• 出版时间：20 July, 2012
• 年：2012
• 卷：212
• 期：2
• 页码：91-96
• 全文大小：943 K

文摘

Orally administered Cd is predominantly distributed to the intestine, and the majority of this mucosal Cd is bound to metallothionein (MT). MT attenuates heavy metal-induced cytotoxicity by sequestering these metals and lowering their intracellular concentrations. In addition, MT acts as an extracellular transporter of orally administered Cd to the kidney. Because of its low molecular weight, the Cd-MT complex is freely filtered at the glomerulus, and the filtered Cd-MT is then incorporated into renal proximal tubular cells. Megalin, a multiligand endocytic receptor (also known as low-density lipoprotein receptor-related protein 2 or Lrp2), acts as the receptor for Cd-MT in a renal proximal tubular cell model. Here, we used the soluble form of 39-kDa receptor-associated protein (sRAP; also known as Lrpap1), a ligand of megalin, to inhibit megalin function, and then analyzed the effect of megalin loss on Cd-MT distribution and Cd-MT-induced nephrotoxicity in an animal model. Administration of sRAP to mice caused acute loss of megalin function by removing megalin in the brush border membrane. The pre-injection of sRAP decreased renal Cd content and decreased Cd-MT-induced kidney damage. Our results demonstrate that sRAP reduces Cd-MT-induced kidney toxicity in vivo.